Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics-Based Tailored H. Pylori Eradication
NCT00149084Phase 3Unknown
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole, clarithromycin, amoxicillin in Helicobacter pylori infection, sponsored by Hamamatsu University School of Medicine. Status: unknown.
02
Drugs
lansoprazoleclarithromycinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00149084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149084.